Beginner
Timing and details
Loading…
Also known as: Ipamorelin acetate · Ipa
Updated 21 sources
How it is thought to work. Ipamorelin binds the ghrelin receptor (GHS-R1a) on the pituitary and fires a GH pulse. In rats and swine it did not raise ACTH or cortisol beyond what GHRH does, even at more than 200 times the dose needed for half its GH effect. GHRP-2 and GHRP-6 did. That is where the 'selective' label comes from. In humans, GH peaked 0.67 hours after an IV dose and then faded.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full Ipamorelin dosage guideEvery titration step in syringe units, missed doses and how to mix.| Water | Strength | 100 mcgdose, units | 200 mcgdose, units | 300 mcgdose, units |
|---|---|---|---|---|
| 2 mg vial | ||||
| 2 mLCompetitor guide† | 1 mg/mL | 100.1 mL | 200.2 mL | 300.3 mL |
| 3 mLCompetitor guide† | 0.667 mg/mL | 150.15 mL | 300.3 mL | 450.45 mL |
| 5 mg vial | ||||
| 2 mLCompetitor guide | 2.5 mg/mL | 40.04 mL | 80.08 mL | 120.12 mL |
| 3 mLCompetitor guide | 1.667 mg/mL | 60.06 mL | 120.12 mL | 180.18 mL |
| 10 mg vial | ||||
| 2 mLCompetitor guide† | 5 mg/mL | 20.02 mL | 40.04 mL | 60.06 mL |
| 3 mLCompetitor guide† | 3.333 mg/mL | 30.03 mL | 60.06 mL | 90.09 mL |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: Ipamorelin in syringe units, with the math shown.Community-reportedFrom 900 Reddit posts and comments, last mined Oct 23, 2026r/Peptides, r/Biohackers, r/Peptidesource, r/PeptideDiscussion
Goal not stated103 mentions
| Reported | Mentions |
|---|---|
| 200 mcg | 23 |
| 250 mcg | 17 |
| 100 mcg | 15 |
| 150 mcg | 12 |
| 300 mcg | 12 |
Muscle growth34 mentions
| Reported | Mentions |
|---|---|
| 100 mcg | 7 |
| 200 mcg | 7 |
| 250 mcg | 5 |
| 300 mcg | 4 |
| 500 mcg | 3 |
Weight loss13 mentions
| Reported | Mentions |
|---|---|
| 200 mcg | 2 |
| 300 mcg | 2 |
| 500 mcg | 2 |
Left out: 2 mentions given in syringe units, which mean different doses in different mixes; 2 mentions far outside every sourced protocol, most likely vial sizes or typos.
| Reported | Mentions |
|---|---|
| Once a day | 69 |
| 5 days on, 2 off | 27 |
| Twice a day | 20 |
| Three times a week | 3 |
Flushing14 mentions
Most common fix: none (2)
Poor sleep11 mentions
Most common fix: switch to morning dosing (4)
Water retention10 mentions
Fatigue7 mentions
Fast heart rate7 mentions
Dizziness6 mentions
Doses shown are what sources report, labelled by origin. Not medical advice.
From clinical trials and regulatory documents.
Any adverse event: 87.5% on ipamorelin vs 94.8% on placebo in 114 patients after bowel surgery
From community reports and dosing guides. Not measured rates.
Guides report it as mild, mostly in weeks 1 to 2
How people manage it
Reported early in a protocol; guides link twice-daily stacked protocols to more fluid retention than once nightly
How people manage it
Some report mild hunger, less than with GHRP-6
Reported with bedtime dosing
Reported by guides
Reported by guides in weeks 1 to 2
Fridge at 2 to 8 °C, or frozen at -20 °C. One guide allows room temperature away from light. Guides quote 18 to 24 months for the powder.
Fridge, 2 to 8 °C. Guides give 21 to 30 days. One notes the 28-day limit comes from the preservative in bacteriostatic water, not from ipamorelin stability data. No ipamorelin stability study was found.
Mixed with: Bacteriostatic water
Mixing. 2 mL in a 5 mg vial is the most repeated choice across guides. 3 mL gives a weaker mix for finer dosing. Use the calculator for units.
CJC-1295 no DAC 100 mcg with ipamorelin 200 to 300 mcg in one syringe, 2 to 3 times daily. A GHRH analog plus a GHRP hits two receptors at once. Some add CJC-1295 with DAC at 2 mg a week instead.
Tesamorelin 2 mg plus ipamorelin 200 mcg, before bed.
Sermorelin and ipamorelin, 200 to 300 mcg each, in one nightly shot.
Paired for fat loss.
Paired for injury recovery.
Human data are a Phase 1 PK study and Phase 2 ileus trials, all IV and lasting up to 7 days. There are no efficacy data for GH-related or body-composition use and no long-term safety data. FDA also lists a literature report of serious adverse events, including death, with IV use.
An approval withdrawn, or removed from FDA's compounding lists.
Not FDA approved for any use. Ipamorelin acetate is in 503B Category 2 (added September 29, 2023) and appears among withdrawn 503A nominations. It is not on the 503A category lists dated May 14, 2026.
FDA's listed concerns are immunogenicity and serious adverse events reported with IV use. WADA 2026 names ipamorelin under S2.2.4, banned at all times.
WADA: Prohibited
Most guides land on 200 to 300 mcg per shot, 1 to 3 times a day. Self-logged doses cluster at 200 to 400 mcg. Beginners often start at 100 to 200 mcg once a day before bed.
Before bed on an empty stomach, so the shot stacks on your natural nighttime GH pulse.
In the human IV study, GH peaked and faded within about an hour, and the response flattened at higher concentrations. A bigger single dose is not a proportionally bigger pulse.
2 mL is the common choice and gives 2.5 mg/mL. Some guides use 3 mL for a weaker mix.
Not in the rat and swine studies that defined it, even at very high doses. GHRP-2 and GHRP-6 did. Human cortisol data at self-use doses were not found.
No. It is not approved for any use and sits in 503B Category 2 for compounding.
About 2 hours, measured after IV infusion in healthy men.
Guides run 8 to 16 weeks on with 4 to 6 weeks off, or 5 days on and 2 off each week. One guide calls 5 on, 2 off a convention, not a trial finding. No trial has tested cycling.
One guide says sleep changes in 1 to 2 weeks and body composition in 4 to 8 weeks. There is no human efficacy data behind those timelines.
Some people report mild hunger. It is less than with GHRP-6.
Guides say yes.
MK-677 (ibutamoren) is an oral, long-acting GH secretagogue. Ipamorelin is injected and short-acting. FDA placed ibutamoren in 503A Category 2 over heart-failure risk.
Yes. WADA lists it under S2.2.4, banned at all times.
About 28 to 30 days in the fridge, per guides.
Only IV studies. A PK study dosed healthy men by infusion, and a Phase 2 trial gave 0.03 mg/kg IV twice daily for up to 7 days after bowel surgery. Time to first tolerated meal was 25.3 vs 32.6 hours on placebo, not a significant difference. A second dose-finding trial with 320 people finished, but results were not found.
Answers come from this site's pages only, with a link to each source.
21 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.